Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Bank China Construction Bank Indonesia Tbk. (MCOR) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Bank China Construction Bank Indonesia Tbk.Trading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Bank China Construction Bank Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Bank China Construction Bank Indonesia Tbk. diperdagangkan di Rp68 (kapitalisasi pasar 2,55 T, volume 24 jam 485,4 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Bank China Construction Bank Indonesia Tbk. jauh lebih besar — sekitar 15,2× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Bank China Construction Bank Indonesia Tbk. lebih aktif diperdagangkan (485,4 rb vs 96,7 rb). Mana yang lebih baik tergantung tujuan investasimu.

MCOROBAT
Kapitalisasi Pasar
2,55 T167,37 M
Volume
485,4 rb96,7 rb
Lot
4,85 rb967
Perputaran
32,56 jt23,82 jt
Harga Rata-rata
67,07246,34
Nilai Transaksi
32,56 jt23,82 jt
Harga Ekuilibrium Indikatif
68248
Volume Ekuilibrium Indikatif
241

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

MCOR
Lihat detail
OBAT
Lihat detail

Tentang Bank China Construction Bank Indonesia Tbk.

PT Bank Multicor (Bank) was established under its original name of PT Multinational Finance Corporation base on notarial deed No.4 of Mr Bagijo, S.H, dated on Apr 2, 1974. The Company’s articles of association has been amended several times, most recently by notarial deed No. 143 of Eliwati Tjitra, S.H., dated Mar 21, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering. The Bank's name was changed to PT Bank Windu Kentjana International Tbk.

Selengkapnya di halaman MCOR

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT